HotSpot Therapeutics, Inc.
HotSpot Therapeutics discovers allosteric medicines that modulate natural regulatory hotspots on proteins to treat cancer, autoimmune and other diseases. The company uses its proprietary Smart Allostery platform, combining structure-function analysis, pharmacology, medicinal chemistry and AI, to identify and design small molecules that bind regulatory pockets remote from active sites. HotSpot operates as a biotechnology company focused on drug discovery and development, and pursues collaborations and licensing with pharmaceutical and biotechnology partners. Its approach aims to produce highly selective, drug-like therapeutics for diseases with limited treatment options. The technology has been applied across oncology and immunology programs and is supported by preclinical data and scientific presentations.
HotSpot Therapeutics, Inc.
HotSpot Therapeutics discovers allosteric medicines that modulate natural regulatory hotspots on proteins to treat cancer, autoimmune and other diseases. The company uses its proprietary Smart Allostery platform, combining structure-function analysis, pharmacology, medicinal chemistry and AI, to identify and design small molecules that bind regulatory pockets remote from active sites. HotSpot operates as a biotechnology company focused on drug discovery and development, and pursues collaborations and licensing with pharmaceutical and biotechnology partners. Its approach aims to produce highly selective, drug-like therapeutics for diseases with limited treatment options. The technology has been applied across oncology and immunology programs and is supported by preclinical data and scientific presentations.
